[
  {
    "ts": null,
    "headline": "When 90% Isn't an A+: Elevance's Cost Crunch and Carelon's Cushion",
    "summary": "ELV trims 2025 outlook as medical costs climb, but commercial growth and Carelon's momentum aim to steady performance.",
    "url": "https://finnhub.io/api/news?id=3b5d890537518345b4d876227ad3c78858a6555b962b10e2667fb36116835f4f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755093720,
      "headline": "When 90% Isn't an A+: Elevance's Cost Crunch and Carelon's Cushion",
      "id": 136339593,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "ELV trims 2025 outlook as medical costs climb, but commercial growth and Carelon's momentum aim to steady performance.",
      "url": "https://finnhub.io/api/news?id=3b5d890537518345b4d876227ad3c78858a6555b962b10e2667fb36116835f4f"
    }
  },
  {
    "ts": null,
    "headline": "Elevance Health, Inc. (ELV) Reports Q2 2025 Results; Mizuho Maintains ‘Buy’ Rating With $342 PT",
    "summary": "With a low price-to-earnings multiple and a significant presence in Seth Klarman’s investment portfolio, Elevance Health, Inc. (NYSE:ELV) earns a spot on our list of the 12 Cheap Value Stocks to Buy Now According to Seth Klarman. On July 17, 2025, Elevance Health, Inc. (NYSE:ELV) released its Q2 2025 results. The company posted adjusted EPS […]",
    "url": "https://finnhub.io/api/news?id=0edb3957c752e96e974342b049161306fd5fb27a367b6fba1a928517ab1d70cd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755056433,
      "headline": "Elevance Health, Inc. (ELV) Reports Q2 2025 Results; Mizuho Maintains ‘Buy’ Rating With $342 PT",
      "id": 136328533,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "With a low price-to-earnings multiple and a significant presence in Seth Klarman’s investment portfolio, Elevance Health, Inc. (NYSE:ELV) earns a spot on our list of the 12 Cheap Value Stocks to Buy Now According to Seth Klarman. On July 17, 2025, Elevance Health, Inc. (NYSE:ELV) released its Q2 2025 results. The company posted adjusted EPS […]",
      "url": "https://finnhub.io/api/news?id=0edb3957c752e96e974342b049161306fd5fb27a367b6fba1a928517ab1d70cd"
    }
  }
]